Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Bullous Pemphigoid Treatment Market: By Mode of Administration: Topical, Injectable, Oral; By Treatment Type: Pain Relief Medication, Steroids, Antibiotics and Antiseptics, Others; By End Use: Hospitals, Special Clinics; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Bullous Pemphigoid Treatment Market Outlook
The global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market, which attained a value of USD 19 billion in 2020. The skin disease treatment market is expected to grow at a CAGR of 3% in the forecast period of 2021-2026 to reach a value of USD 23 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Accessibility of Healthcare Facilities to Aid the Market Growth of Bullous Pemphigoid Treatment
Region-wise, Europe is a significant region for bullous pemphigoid treatment, contributing to a significant market share. This could be attributed to the high incidence rate of the disease, i.e., 6/7 cases per 1 million persons per year, and accessibility of healthcare facilities within every section of the region. Europe is followed by North America as a large proportion of healthcare providers and treatment centres reside in the region. The market is further aided by the improved technology and reimbursement scenarios that enhance the growth in these regions. Within the Asia Pacific and the Middle East, the countries are expected to witness an exponential growth over the forecast period owing to government efforts in enhancing healthcare facilities and raising awareness in the region owing to the disease and the availability of treatment options.
Bullous Pemphigoid Treatment: Industry Definition and Segmentation
Bullous pemphigoid treatment involves the treatment of bullous pemphigoid, which is a chronic, inflammatory skin disease that entails the formation of blisters. The bullous varies from generalised, vegetative, urticarial, nodular, vesicular, acral, or infant forms. The incidences of this disease have been more in younger adults and rare in infants. The treatment of bullous pemphigoid involves pain relief medication, ultra-potent, moderate steroids, antibiotics and antiseptics for bacterial infections, and immunosuppressant medication.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of mode of administration, the market is divided into:
- Topical
- Injectable
- Oral
Based on treatment type, the industry can be segmented into:
- Pain Relief Medication
- Steroids
- Antibiotics and Antiseptics
- Others
By end use, the industry is categorised into:
- Hospitals
- Special Clinics
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Geriatric Population Globally to Aid the Market Growth of Bullous Pemphigoid Treatment
The market for bullous pemphigoid treatment is being driven by the increasing geriatric population globally, which has led to the heightened rate of occurrence of the disease, and, therefore, the increase in treatment options. The market is further boosted by the common as well as non-expensive medication used in the treatment of the disease. In addition, numerous awareness programmes organised by healthcare organisations and NGOs encourage the proliferation of the market. However, the unavailability of healthcare facilities in several less developed regions across the globe having a rising incidence of the disease limits the market growth of bullous pemphigoid treatment.
Key Industry Players in the Global Bullous pemphigoid treatment Market
The report gives a detailed analysis of the following key players in the global bullous pemphigoid treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Mode of Administration, Treatment Type, End Use, Region |
| Breakup by Mode of Administration | Topical, Injectable, Oral |
| Breakup by Treatment Type | Pain Relief Medication, Steroids, Antibiotics and Antiseptics, Others |
| Breakup by End Use | Hospitals, Special Clinics, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | F. Hoffmann-La Roche Ltd, Pfizer Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Bullous Pemphigoid Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Bullous Pemphigoid Treatment Historical Market (2016-2020)
8.3 Global Bullous Pemphigoid Treatment Market Forecast (2021-2026)
8.4 Global Bullous Pemphigoid Treatment Market by Mode of Administration
8.4.1 Topical
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Injectable
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Oral
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.5 Global Bullous Pemphigoid Treatment Market by Treatment Type
8.5.1 Pain Relief Medication
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Steroids
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Antibiotics and Antiseptics
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.4.5 Others
8.6 Global Bullous Pemphigoid Treatment Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Special Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Others
8.7 Global Bullous Pemphigoid Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles (*This list is only indicative. The report contains a more comprehensive list of players.)
11.2.1 F. Hoffmann-La Roche Ltd
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Pfizer Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Others
12 Industry Events and Development
List of Figures and Tables
1. Global Bullous Pemphigoid Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Bullous Pemphigoid Treatment Historical Market: Breakup by Mode of Administration (USD Million), 2016-2020
3. Global Bullous Pemphigoid Treatment Market Forecast: Breakup by Mode of Administration (USD Million), 2021-2026
4. Global Bullous Pemphigoid Treatment Historical Market: Breakup by Treatment Type (USD Million), 2016-2020
5. Global Bullous Pemphigoid Treatment Market Forecast: Breakup by Treatment Type (USD Million), 2021-2026
6. Global Bullous Pemphigoid Treatment Historical Market: Breakup by Mode of Administration (USD Million), 2016-2020
7. Global Bullous Pemphigoid Treatment Market Forecast: Breakup by Mode of Administration (USD Million), 2021-2026
8. Global Bullous Pemphigoid Treatment Historical Market: Breakup by End Use (USD Million), 2016-2020
9. Global Bullous Pemphigoid Treatment Market Forecast: Breakup by End Use (USD Million), 2021-2026
10. Global Bullous Pemphigoid Treatment Historical Market: Breakup by Region (USD Million), 2016-2020
11. Global Bullous Pemphigoid Treatment Market Forecast: Breakup by Region (USD Million), 2021-2026
12. North America Bullous Pemphigoid Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
13. North America Bullous Pemphigoid Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Europe Bullous Pemphigoid Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
15. Europe Bullous Pemphigoid Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Asia Pacific Bullous Pemphigoid Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
17. Asia Pacific Bullous Pemphigoid Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Latin America Bullous Pemphigoid Treatment Historical Market: Breakup by Country (USD Million), 2016-2020.
19. Latin America Bullous Pemphigoid Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
20. Middle East and Africa Bullous Pemphigoid Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
21. Middle East and Africa Bullous Pemphigoid Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
22. Global Bullous Pemphigoid Treatment Market Structure
Key Questions Answered in the Report
In 2020, the global bullous pemphigoid treatment market is being aided by the rising skin disease treatment market, which attained a value of nearly USD 19 billion.
The skin disease treatment market is projected to grow at a CAGR of 3% between 2021 and 2026, further aiding the growth of the bullous pemphigoid treatment industry.
The skin disease treatment market is estimated to reach about USD 23 billion by 2026 and is expected to continue to support the growth of bullous pemphigoid treatment industry.
The major drivers of the industry, such as rising disposable incomes, increasing geriatric population, high incidence rate of the disease, and increasing accessibility of healthcare facilities, are expected to aid the market growth.
The key market trend guiding the growth of the industry include government efforts in enhancing healthcare facilities and rising awareness.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading modes of administration in the market are topical, injectable, and oral.
The major treatment types in the industry are pain relief medication, steroids, pain relief medication, and antibiotics and antiseptics, among others.
The significant end use sectors in the market are hospitals and special clinics, among others.
The major players in the industry are F. Hoffmann-La Roche Ltd and Pfizer Inc., among others.
Analyst Review
The global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market, which attained a value of USD 19 billion in 2020. Aided by the growing accessibility of healthcare facilities, the skin disease treatment market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 3%. The skin disease treatment market is projected to reach USD 23 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By mode of administration, the market is segmented into topical, injectable, and oral. On the basis of treatment type, the industry is divided into pain relief medication, steroids, and antibiotics and antiseptics, among others. Based on end use, the market is segmented into hospitals and special clinics, among others. The major regional markets for bullous pemphigoid treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd and Pfizer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global therapeutic beds market attained a value of USD 3.37 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 5.38% to reach USD 4.61 billion...
The global allergy treatment market attained a value of 17.9 billion in 2020, driven by the growing popularity of immunotherapy. Aided by the growing R&D activities towards the development of anti-all...
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2021-2026 to attain a v...
The global sickle cell disease treatment market stood at a value of around USD 3.4 billion in 2020. The market is further expected to grow at a CAGR of 16.9% in the forecast period of 2021-2026 to att...
The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the ...
NEWSLETTER